Breast Cancer Clinical Trials in Cincinnati, OH

Breast Cancer Clinical Trials in Cincinnati, OH

View the best 10 breast cancer medical studies in Cincinnati, Ohio. Access promising new therapies by applying to a Cincinnati-based Breast Cancer clinical trial.

Trials in Cincinnati, Ohio

Here are the top 10 medical studies for breast cancer in Cincinnati, Ohio

Image of Wake Forest School of Medicine in Winston-Salem, United States.

Choice PRO vs Fixed PRO

Recruiting1 award11 criteria
This trial is testing if letting people choose which health questionnaire to fill out leads to more people filling it out and if they find it more acceptable.
Image of University of California at Davis in Davis, United States.

ONC-392 +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Image of University of Alabama in Birmingham, United States.

Proton +1 More

Proton Beam Therapy

Recruiting1 award12 criteria
This trial is testing whether proton therapy or photon therapy is better for treating breast cancer. It will follow patients for side effects, quality of life, and cancer control.
Image of Fairbanks Memorial Hospital in Fairbanks, United States.

No Radiation +1 More

Recruiting2 awardsPhase 3
This trial is testing whether omitting regional radiation therapy for low-risk breast cancer is non-inferior to usual care.
Image of Royal Victoria Regional Health Centre in Barrie, Canada.

Giredestrant +1 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.
Image of Mercy Medical Center in Baltimore, United States.

Elacestrant

Selective Estrogen Receptor Degrader

Recruiting2 awardsPhase 3
"This trial aims to compare a new drug called elacestrant with the usual hormone therapy for early breast cancer patients with a high risk of cancer coming back. The study will see which treatment is more
Image of SWOG in Portland, United States.

Paclitaxel +3 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial will compare the effects of adding an immunotherapy drug (durvalumab) to usual chemotherapy to usual chemotherapy alone in treating breast cancer.
Image of Gabrail Cancer Center in Canton, United States.

Abemaciclib +1 More

CDK4/6 Inhibitor

Recruiting1 awardPhase 1 & 2
This trial tests a combination of two drugs, elacestrant and abemaciclib, in patients with a specific type of breast cancer. It aims to find the best dose and see how well it works for those whose cancer has spread to the brain. The drugs work by blocking signals that help cancer cells grow and divide. Abemaciclib is a drug that has been approved for the treatment of certain advanced breast cancers.
Image of NRG Oncology in Philadelphia, United States.

Fulvestrant

Hormone Therapy

Recruiting1 awardPhase 2
This trial is testing whether adding binimetinib to the usual treatment of fulvestrant can help patients with a specific type of advanced breast cancer. Fulvestrant works by blocking estrogen receptors on cancer cells, while binimetinib stops enzymes that help cancer grow. The goal is to see if this combination can better control the cancer compared to using fulvestrant alone.
Image of King Regional Medical Center in Kingman, United States.

Chemotherapy

Recruiting1 awardPhase 2
This trial tests an imaging procedure in patients with a specific type of breast cancer. The test uses a small amount of radioactive sugar to highlight active cancer areas, helping doctors decide if more or less treatment is needed before surgery. This imaging procedure has been used successfully for diagnosis, initial staging, restaging, early treatment response assessment, evaluation of disease spread, and predicting outcomes in breast cancer.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.